OXiGENE Inc. announced a restructuring plan designed to focus the company's capital resources on its early-stage clinical programs and further reduce its cash utilization.
Examining brain damage that occurs when fetuses in the womb are deprived of oxygen, researchers at The Scripps Research Institute have discovered that damage does not occur randomly but is linked to the specific action of a naturally occurring fatty molecule called LPA, acting through a receptor that transfers information into young brain cells.
An investigation into the mysterious inner workings of the malaria parasite revealed that it survives and proliferates in the human bloodstream thanks in part to a single, crucial chemical that the parasite produces internally.
Cancer scientists have long debated whether all cells within a tumor are equal or whether some cancer cells are more potent: a question that has been highly investigated in experimental models in the last decade.
University of Florida researchers have modified a toxic chemical produced by tiny marine microbes and deployed it against laboratory models of colon cancer.
G-Biosciences EndotoxinOUT is designed to remove endotoxins from buffers, cell culture media, protein solutions, nucleic acid samples, and pharmacological components.
Mettler Toledo announces the availability of a Fourier transform infrared spectroscopy instrument, FlowIR. As one of the smallest FTIR instruments, FlowIR can be placed nearly anywhere along a reactor setup.
Aridhia Informatics Ltd and Glencoe Software have formed a strategic partnership to create innovative products to aid the development of personalized therapies and deliver improved patient outcomes.
Kuros Biosurgery AG announced that it has completed recruitment in a Phase 2b clinical trial designed to investigate KUR-211 in the treatment of diabetic foot ulcers.
Immune System Therapeutics Limited announced it had secured patent protection for a new method of treating blood cancers that express a target called lambda myeloma antigen.
Our immune system is capable of a remarkable feat: the ability to remember infections for years, even decades, after they have first been encountered and defeated.
Researchers have demonstrated an approach to HIV vaccine design that uses an altered form of HIV's outer coating or envelope protein. The design could bind better to immature B cell receptors creating an enhanced immune response.
Drugmaker Pfizer Inc. for a second time is extending its tender offer for pain drug developer Icagen, as the number of shares tendered again fell short of what Pfizer needed.
Researchers have discovered that dendritic cells in the liver have a protective role against the toxicity of acetaminophen, the widely used over-the-counter pain reliever and fever reducer for adults and children.